Words 'The upper nasal space where no migraine meds have gone before'
A product image of Trudhesa® Precision Olfactory Delivery (POD®) upright facing right
Precision Olfactory Delivery (POD®) technology sends medicine directly to the upper nasal space so you don’t have to worry about it dripping down onto your upper lip or the back of your throat. And unlike other migraine nasal sprays, you don’t have to tilt your head or coordinate sniffing and inhaling. Trudhesa™ does the work for you.*
*People in a study noted that Trudhesa had less dripping (32% vs 77%), less post-nasal drip (32% vs 56%), and was easier to use (71% vs 53%) than a previous DHE nasal spray product.
Ready for Trudhesa? Just be DIRECT
All you need to remember is Be DIRECT. Please follow complete Instructions for Use, provided with the product.
Partial view of opened Trudhesa® Precision Olfactory Delivery (POD®) package showing the POD and medication vial
'D'

Determine everything is good to go

'I'

Install vial and POD together

'R'

Ready the POD by priming

'E'

Engage POD to nose

'C'

Complete your dose with one spray per nostril.

'T'

Toss as it can only be used once.

Image of an actor portrayal of Trudhesa patient smiling with short hair, looking to the left

Getting Trudhesa

Serious or potentially life-threatening reductions in blood flow to the brain or extremities due to interactions between dihydroergotamine (the active ingredient in Trudhesa) and strong CYP3A4 inhibitors (such as protease inhibitors and macrolide antibiotics) have been reported rarely. As a result, these medications should not be taken together.
Indication
Trudhesa is used to treat an active migraine headache with or without aura in adults. Do not use Trudhesa to prevent migraine when you have no symptoms. It is not known if Trudhesa is safe and effective in children.
Do not use Trudhesa if you:
  • Have any disease affecting your heart, arteries, or blood circulation
  • Are taking certain anti-HIV medications known as protease inhibitors (such as ritonavir or nelfinavir)
  • Are taking a macrolide antibiotic such as clarithromycin or erythromycin
  • Are taking certain antifungals such as ketoconazole or itraconazole
  • Have taken certain medications such as triptans or ergot-type medications for the treatment or prevention of migraine within the last 24 hours
  • Have taken any medications that constrict your blood vessels or raise your blood pressure
  • Have severe liver or kidney disease
  • Are allergic to ergotamine or dihydroergotamine
Before taking Trudhesa, tell your doctor if:
  • You have high blood pressure, chest pain, shortness of breath, heart disease; or risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease or you are postmenopausal, or male over 40); or problems with blood circulation in your arms, legs, fingers, or toes.
  • You have or had any disease of the liver or kidney.
  • You are taking any prescription or over-the-counter medications, including vitamins or herbal supplements.
  • You are pregnant, planning to become pregnant or are nursing, or have ever stopped medication due to an allergy or bad reaction.
  • This headache is different from your usual migraine attacks.

The use of Trudhesa should not exceed dosing guidelines and should not be used on a daily basis.

Serious cardiac (heart) events, including some that have been fatal, have occurred following the use of dihydroergotamine mesylate, particularly with dihydroergotamine for injection, but are extremely rare.

You may experience some nasal congestion or irritation, altered sense of taste, sore throat, nausea, vomiting, dizziness, and fatigue after using Trudhesa.

Contact your doctor immediately if you experience:

  • Numbness or tingling in your fingers and toes
  • Severe tightness, pain, pressure, heaviness, or discomfort in your chest
  • Muscle pain or cramps in your arms or legs
  • Cold feeling or color changes in 1 or both legs or feet
  • Sudden weakness
  • Slurred speech
  • Swelling or itching

The risk information provided here is not comprehensive. To learn more, talk about Trudhesa with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at www.trudhesa.com or 1-800-555-DRUG. You can also call 1-833-TRUDHESA (1-833-878-3437) for additional information.